Sep 08, 2020
ArcherDX to Participate in Morgan Stanley 18th Annual Global Healthcare Conference
Aug 05, 2020
ArcherDX to Participate in UBS Genomics 2.0 and Medtech Innovations Virtual Summit
Jun 22, 2020
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
Jun 18, 2020
ArcherDX Enters Collaboration with Bristol Myers Squibb to Apply Personalized Cancer Monitoring (PCM(TM)) to Clinical Research
May 26, 2020
ArcherDX Announces Strategic Collaboration with AstraZeneca to Develop Personalized Cancer Monitoring (PCM) Assays for Minimal Residual Disease (MRD)
May 19, 2020
ArcherDX Receives Breakthrough Device Designation to Detect NTRK Gene Fusions
May 07, 2020
ArcherDX Appoints Jason Ryan to Board of Directors
Apr 28, 2020
ArcherDX and UCL Present New Minimal Residual Disease Surveillance Data from their Collaboration at 2020 AACR Virtual Annual Meeting
Apr 21, 2020
ArcherDX and Premier Inc. Partner to Deliver Personalized Genomic Testing to Patients
Apr 15, 2020
Natera Asserts Three New Oncology Patents Against ArcherDX
Mar 25, 2020
ArcherDX Receives Approval for Archer®MET Companion Diagnostic for TEPMETKO® (Tepotinib) in Advanced Non-Small Cell Lung Cancer in Japan
Jan 27, 2020
Natera Files Suit Against ArcherDX for Patent Infringement
Jan 14, 2020
ArcherDX Personalized Cancer Monitoring (PCM) Technology Designated by FDA as Breakthrough Device
Jan 10, 2020
ArcherDX and Illumina Partner for Future to Co-Market Portfolio of Planned In-Vitro Diagnostic (IVD) Tests
Jan 07, 2020
ArcherDX Appoints Mark Massaro Chief Financial Officer
Dec 17, 2019
ArcherDX Announces Close of $55 Million Series C Financing
Jul 08, 2019
ArcherDX and Ayala Pharmaceuticals Announce Strategic Companion Diagnostic Collaboration
May 29, 2019
ArcherDX Announces the Appointment of Steven J. Kafka, Ph.D. as Executive Chairman of the Board of Directors
Mar 28, 2019
ArcherDX announces collaboration with University College London to Investigate the Novel Use of Cell-Free Circulating Tumor DNA to Detect Disease Recurrence in Lung Cancer Patients
Feb 12, 2019
ArcherDX Announces Broad-Based Strategic Collaboration with Genosity